LLY vs MRK
Eli Lilly and Company vs Merck & Co. — AI-powered side-by-side comparison
| Metric | LLY | MRK |
|---|---|---|
| AI Score | 63 | 59 |
| Price | $1,188.57 | $123.48 |
| P/E Ratio | 45.52× | 34.71× |
| ROE | 101.3% | 17.9% |
| Revenue Growth YoY | 47.4% | 2.9% |
| Gross Margin | 82.8% | 78.1% |
| Debt / Equity | 1.60× | 0.94× |
| Dividend Yield | 0.6% | 2.7% |
| RSI (14) | 51.0 | 45.9 |
| Beta | 0.5022 | 0.21 |
| Expected Upside | — | +0.4% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
LLY Full Analysis
MRK Full Analysis